產(chǎn)品訂購(gòu)信息：
英文名稱  Anti-TRIM11/RNF92 

中文名稱   環(huán)指蛋白92抗體費(fèi)用 

別    名  BIA 1; E3 ubiquitin protein ligase TRIM11; E3 ubiquitin-protein ligase TRIM11; Protein BIA1; RING finger protein 92; RNF 92; TRI11_HUMAN; Trim 11; TRIM11; Tripartite motif containing 11; tripartite motif protein 11; Tripartite motif-containing protein 11.

濃    度   1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來(lái)源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep 

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 53kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human TRIM11/RNF92 

亞    型   IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

環(huán)指蛋白92抗體費(fèi)用 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 E3 ubiquitin-protein ligase that promotes the degradation of insoluble ubiquitinated proteins, including insoluble PAX6, poly-Gln repeat expanded HTT and poly-Ala repeat expanded ARX. Mediates PAX6 ubiquitination leading to proteasomal degradation, thereby modulating cortical neurogenesis. May also inhibit PAX6 transcriptional activity, possibly in part by preventing the binding of PAX6 to its consensus sequences. May contribute to the regulation of the intracellular level of HN (humanin) or HN-containing proteins through the proteasomal degradation pathway. Mediates MED15 ubiquitination leading to proteasomal degradation. May contribute to the innate restriction of retroviruses. Upon overexpression, reduces HIV-1 and murine leukemia virus infectivity, by suppressing viral gene expression. Antiviral activity depends on a functional E3 ubiquitin-protein ligase domain. May regulate TRIM5 turnover via the proteasome pathway, thus counteracting the TRIM5-mediated cross-species restriction of retroviral infection at early stages of the retroviral life cycle.

Function : E3 ubiquitin-protein ligase that promotes the degradation of insoluble ubiquitinated proteins, including insoluble PAX6, poly-Gln repeat expanded HTT and poly-Ala repeat expanded ARX. Mediates PAX6 ubiquitination leading to proteasomal degradation, thereby modulating cortical neurogenesis. May also inhibit PAX6 transcriptional activity, possibly in part by preventing the binding of PAX6 to its consensus sequences. May contribute to the regulation of the intracellular level of HN (humanin) or HN-containing proteins through the proteasomal degradation pathway. Mediates MED15 ubiquitination leading to proteasomal degradation. May contribute to the innate restriction of retroviruses. Upon overexpression, reduces HIV-1 and murine leukemia virus infectivity, by suppressing viral gene expression. Antiviral activity depends on a functional E3 ubiquitin-protein ligase domain. May regulate TRIM5 turnover via the proteasome pathway, thus counteracting the TRIM5-mediated cross-species restriction of retroviral infection at early stages of the retroviral life cycle.

Subunit : Binds cytoplasmic tail of integrin alpha-1. Interacts with the HN peptide (By similarity). Interacts with PHOX2B (By similarity). Interacts with PAX6 (By similarity). Interacts with MED15/ARC105; this interaction leads to MED15 ubiquitination and proteasomal degradation.

Subcellular Location : Cytoplasm. Nucleus.

Tissue Specificity : Ubiquitous.

Similarity : Belongs to the TRIM/RBCC family.

Contains 1 B box-type zinc finger.

Contains 1 B30.2/SPRY domain.

Contains 1 RING-type zinc finger.

Database links : UniProtKB/Swiss-Prot: Q96F44.2

Anti-IL-16/FITC 熒光素標(biāo)記白介素16抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rabbit Anti-human sIgA/FITC 熒光素標(biāo)記兔抗人分泌型IgA抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Apg12 自噬相關(guān)蛋白12抗體 規(guī)格 0.2ml

Rabbit Anti-rat IgG/RBITC 羅丹明標(biāo)記的兔抗大鼠IgG 0.3ml

GIMAP6 英文名稱： GTP酶IMAP家族成員6抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-human sIgA/Alexa Fluor 350 Alexa Fluor 350標(biāo)記的兔抗人分泌型IgA 規(guī)格 0.1ml

Rabbit Anti-human sIgA/FITC 熒光素標(biāo)記兔抗人分泌型IgA抗體Multi-class antibodies規(guī)格： 0.2ml

NOS-2 peptide 合成酶-2多肽抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh phospho-ATG7(Ser95) 磷酸化自噬相關(guān)蛋白7抗體 規(guī)格 0.1ml

山羊抗人 IgM/HRP 0.1ml 美國(guó)Jackson公司分裝

Viperin 英文名稱： 病毒抑制蛋白Viperin抗體 0.2ml

Dio3 英文名稱： 甲狀腺素5'脫酶3抗體 0.1ml

Anti-AQP2 水通道蛋白-2抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-CD64/PE 熒光素PE標(biāo)記免疫球蛋白G Fc段受體IMulti-class antibodies規(guī)格： 0.2ml

Elastin 彈性蛋白抗原Multi-class antibodies規(guī)格： 0.5mg

活化轉(zhuǎn)錄因子4抗體 Anti-ATF4 0.1ml

ZFX 英文名稱： 鋅指蛋白X染色體蛋白抗體 0.2ml

DUSP1 英文名稱： 原活化蛋白激酶磷酸酶-1抗體 0.1ml

Rhesus antibody Rh Phospho-eIF2 alpha (Ser51) 磷酸化真核啟動(dòng)因子2α抗體 規(guī)格 0.1ml

Elastin 彈性蛋白抗原Multi-class antibodies規(guī)格： 0.5mg

人β2糖蛋白1抗體IgG(β2-GP1 Ab IgG)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝

兔子催乳素(PRL/LTH)免疫試劑盒 Rabbit Prolactin/Leoopic Hormone,PRL/LTH ELISA Kit

乳鐵傳遞蛋白/乳鐵蛋白(LF/LTF)ELISA試劑盒 ，英文名： LF/LTF ELISA Kit

PorcinePulmonarysurfatca-associatedproteinA,SP-AELISA試劑盒豬肺表面活性物質(zhì)相關(guān)蛋白A(SP-A)ELISA試劑盒規(guī)格：96T/48T

humanangiotensinⅡreceptoypeⅠa,AgⅠaELISA試劑盒人緊張素Ⅱ受體Ⅰa型(AgⅠa)ELISA試劑盒規(guī)格：96T/48T

HumanaoaibodiesagainsttheC-terminaldomainⅣ,ACAST-DⅣELISAKit人抗鈣蛋白酶抑素抗體(ACAST-DⅣ)ELISA試劑盒規(guī)格：96T/48T

大鼠生長(zhǎng)抑素(SS)ELISA試劑盒 ，英文名： SS ELISA Kit

人癌胚鐵蛋白(CEF)ELISA檢測(cè)試劑盒HumanCarcinoembryonicFerritin,CEFELISAKit 96T/48T

海獅皮質(zhì)醇(Coisol)免疫試劑盒 Sea Lion Coisol ELISA kit

CLIAKitforpMHC(Humanpeptidemajorhistocompatibilitycomplex)ELISAKit人肽-主要組織相容性復(fù)合體復(fù)合物規(guī)格：48T/96T

石蠟切片組織PAR-2蛋白表達(dá)熒光顯微鏡檢測(cè)試劑盒10/20次

ELISAKitDAO人氧化酶規(guī)格：48T/96T

環(huán)指蛋白92抗體費(fèi)用 大鼠脫氫表雄酮酯(DHEA-S)ELISA 試劑盒 96T/48T 試劑盒 組裝/原裝

人微管相關(guān)蛋白2(MAP-2)免疫試劑盒 Human MAP-2 ELISA Kit

血清游離膽固醇(FC)含量測(cè)試盒 可見(jiàn)分光光度法 50管/48樣

RatP-SelectinELISA試劑盒大鼠P選擇素(P-Selectin/CD62P)ELISA試劑盒規(guī)格：96T/48T

HumanIerleukin11,IL-11ELISA試劑盒人白介素11(IL-11)ELISA試劑盒規(guī)格：96T/48T

HumanMotilin,MTLELISAKit人活性腸肽(VIP)ELISA試劑盒規(guī)格：96T/48T

抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：

1. 環(huán)指蛋白92抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；

3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

抗體的鑒定：

1）環(huán)指蛋白92抗體費(fèi)用 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。